Release date: 2016-12-30

Recently, in the newly-launched "Times" 2016 "To make the world a better place" in the list of innovative inventions, the "artificial pancreas" developed by the world's leading medical technology company Medtronic and other 24 cool products were on the list. .

The insulin pump system, called the MiniMed® 670G, was recently approved by the US Food and Drug Administration (FDA) as the world's first hybrid closed-loop insulin infusion system to receive regulatory approval from the regulatory authorities. The system is equipped with the most advanced SmartGuard(TM) algorithm, which simplifies and improves diabetes management through intelligent actuarial management, enabling more effective glycemic control while reducing patient input and operation.

Medtronic's "Artificial Pancreas" on the list of "Times" best invention

Highlights on the list 1: Bring your own 24-hour actuary

With the help of SmartGuard HCL Actuarial, the MiniMed® 670G insulin pump system enables individualized treatment, allowing patients and healthcare providers to benefit from automated glycemic management to a greater extent, tailoring and implementing the unique needs of each patient. The individual's optimal sugar control program.

People with diabetes need to check their blood sugar frequently to adjust the amount of insulin or diet, which brings great inconvenience to their lives. The MiniMed® 670G blood glucose meter is only iPod size and can be carried around. It measures the patient's blood sugar every five minutes, automatically adjusts the insulin dose, and maintains the patient's blood sugar stability.

“SmartGuard HCL's actuarial system enables a fully automated infusion of basic insulin 24 hours a day, a new feature that will have a profound impact on diabetes disease management, especially in dramatically reducing blood glucose variability and prolonging blood glucose in the normal range. Time.” Dr. Richard M. Bergenstal, Ph.D., the lead investigator of the prospective clinical trial at MiniMed® 670G, and the Executive Director of the International Diabetes Center in Minneapolis, USA, told us.

Professor Fran Kaufman, chief medical officer of the Medtronic Diabetes Group, said: “Patients can spend less time managing their illness and spending more time enjoying life.”

Highlights on the list 2: 24 hours continuous monitoring

Another major feature of the MiniMed 670G system is the Guardian® Sensor's latest blood glucose sensor, which offers higher accuracy, better performance and longer life (7 days). As the first and currently FDA-approved sensor for a hybrid closed-loop insulin infusion system, the Guardian® Sensor is equipped with a device diagnostic technology that continuously monitors the sensor's operating status. Driven by SmartGuardHCL, the system infusions insulin in a flexible and versatile manner 24 hours a day, depending on the individual's needs, to maximize the duration of blood glucose in the normal range.

The system can automatically sense the insulin needs of individual patients, so as to take timely measures to minimize the occurrence of hyperglycemia or hypoglycemia. Therefore, the only manual step for patients to use this system is to enter the carbohydrate intake during meals, accept large dose corrections and periodically calibrate the sensor.

"The FDA's approval of the world's first hybrid closed-loop insulin infusion system has brought us years of hard work in this area, and our long-standing close collaboration with clinicians and patients has reached a new climax," Medtronic Diabetes Business Group Chief Medical Officer Francine Kaufman said, “We are very grateful to the FDA for approving our PMA application at an unprecedented rate, enabling us to quickly apply this advanced insulin pump treatment to patients suffering from diabetes in the United States. ."

Mr. Francine Kaufman also expressed his gratitude for the innovation and invention of 2016. He is also very grateful to Time magazine for his concern and encouragement for medical technology innovation. Medtronic will also continue to benefit from the continuous innovation of science and technology to benefit more diabetes worldwide. patient.

Source: Phoenix Health

Others

Plastic additives, also known as plastic additives, are compounds that must be added to polymers (synthetic resins) to improve their processing properties or to improve the properties of the resin itself. For example, in order to reduce the molding temperature of PVC resin, to make the product soft and added plasticizer; Another example is to add foaming agent in order to prepare light weight, anti - vibration, heat insulation, sound insulation foam plastics; The thermal decomposition temperature of some plastics is very close to the molding temperature, and the molding cannot be done without adding heat stabilizer. Therefore, the plastic assistant agent occupies a particularly important position in the plastic forming process. A class of auxiliary agents for plastic molding products, including plasticizer, heat stabilizer, antioxidant, light stabilizer, flame retardant, foaming agent, antistatic agent, mildew agent, colorant and whitening agent (see pigment), filler, coupling agent, lubricant, mold release agent and so on. Colorants, brighteners and fillers are not special plastics chemicals, but the general use of materials.

Versatile Biobased Polyols,Bio-Based Versatile Biobased Polyols,Materials For Pu Foam Applications,Self-Catalytic Polyols For Spray Application

Xingbang High Molecular Materials Co., Ltd. , https://www.chemicaladditive.com